Back to top
more

Nu Skin Enterprises (NUS)

(Real Time Quote from BATS)

$9.08 USD

9.08
390,052

+0.88 (10.73%)

Updated Aug 8, 2025 01:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (160 out of 244)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Things to Know Ahead of Boston Beer's (SAM) Q3 Earnings

by Zacks Equity Research

Boston Beer's (SAM) Q3 results are likely to reflect continued gains from strength in depletions and shipments. Disruptions in on-premise and higher costs are expected to have marred its performance.

Zacks Equity Research

Procter & Gamble (PG) Q1 Earnings & Sales Beat, Stock Up

by Zacks Equity Research

Procter & Gamble's (PG) first-quarter fiscal 2021 results reflect top-line gains across all segments as well as a rise in organic shipment volume, and improved pricing and mix.

Zacks Equity Research

Will Coca-Cola (KO) Retain Positive Earnings Trend in Q3?

by Zacks Equity Research

Coca-Cola's (KO) third-quarter 2020 results are expected to reflect benefits from growth of e-commerce and gradually improving away-from-home trends as restrictions ease.

Zacks Equity Research

Here's Why Nu Skin (NUS) is Up About 20% in Three Months

by Zacks Equity Research

Nu Skin's (NUS) focus on empowering sales leaders through engaging technology platforms is yielding.

Zacks Equity Research

All You Should Know Before Philip Morris' (PM) Q3 Earnings

by Zacks Equity Research

Philip Morris' (PM) third-quarter 2020 results are likely to reflect soft duty-free sales due to the pandemic-led travel restrictions. However, strength in reduced-risk products should aid.

Zacks Equity Research

NUS vs. EL: Which Stock Is the Better Value Option?

by Zacks Equity Research

NUS vs. EL: Which Stock Is the Better Value Option?

Zacks Equity Research

Should Value Investors Buy Nu Skin Enterprises (NUS) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Is Nu Skin Enterprises (NUS) Stock Outpacing Its Consumer Staples Peers This Year?

by Zacks Equity Research

Is (NUS) Outperforming Other Consumer Staples Stocks This Year?

Zacks Equity Research

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

by Zacks Equity Research

Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Nu Skin (NUS) Rallies on Impressive Sales Projection for Q3

by Zacks Equity Research

Nu Skin (NUS) anticipates third-quarter 2020 revenues in the range of $700-$703 million ahead of its previously provided guidance.

Zacks Equity Research

Strength Seen in Nu Skin (NUS): Stock Soars 9.6%

by Zacks Equity Research

Nu Skin (NUS) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Zacks Equity Research

Zacks.com featured highlights include: Zumiez, Installed Building Products, 1-800-FLOWERS.COM, Medifast and Nu Skin

by Zacks Equity Research

Zacks.com featured highlights include: Zumiez, Installed Building Products, 1-800-FLOWERS.COM, Medifast and Nu Skin

Radhika Pujara headshot

Bet on These 5 Top-Ranked Liquid Stocks for Fat Returns

by Radhika Pujara

Here are five top-ranked liquid stocks, including Nu Skin Enterprises (NUS), that investors can snap up for enhancing portfolio returns.

Zacks Equity Research

Is Nu Skin Enterprises (NUS) a Good Value Investor Stock?

by Zacks Equity Research

Let's see if Nu Skin Enterprises (NUS) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Equity Research

NUS vs. EL: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

NUS vs. EL: Which Stock Is the Better Value Option?

Zacks Equity Research

Is Nu Skin Enterprises (NUS) Stock Outpacing Its Consumer Staples Peers This Year?

by Zacks Equity Research

Is (NUS) Outperforming Other Consumer Staples Stocks This Year?

Zacks Equity Research

Nu Skin is Poised on Customer Base Growth & Product Pipeline

by Zacks Equity Research

Strength in Nu Skin's (NUS) customer base driven by its effective strategies is yielding. Also, it is focused on empowering sales leaders through engaging technology platforms.

Zacks Equity Research

Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder

by Zacks Equity Research

Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder

Zacks Equity Research

NUS or HELE: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

NUS vs. HELE: Which Stock Is the Better Value Option?

Zacks Equity Research

4 Cosmetics Stocks to Buff Up Your Portfolio Amid Industry Challenges

by Zacks Equity Research

The Zacks Cosmetics industry is facing COVID-19 woes like disturbed travel retail, low traffic and soft makeup demand. Rising demand for personal care products however bodes well for HELE, NUS, IPAR and ELF, which are focused on adapting to the changing market trends.

Zacks Equity Research

Inter Parfums Down on 2020 View, Travel Retail Woes to Stay

by Zacks Equity Research

Inter Parfums (IPAR) expects net sales of roughly $442 million for 2020, indicating a decline from 2019 levels. Travel retail is likely to remain under pressure.

Zacks Equity Research

Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?

by Zacks Equity Research

Is (NUS) Outperforming Other Consumer Staples Stocks This Year?

Zacks Equity Research

Here's Why Nu Skin Stock is Up More Than 20% in Three Months

by Zacks Equity Research

Nu Skin (NUS) is seeing robust growth in its customer base courtesy of its effective strategies. Also, management recently raised its 2020 outlook.

Zacks Equity Research

Nu Skin (NUS) Up 0.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Zacks.com featured highlights include: IBP, MED, NUS and LOGI

by Zacks Equity Research

Zacks.com featured highlights include: IBP, MED, NUS and LOGI